MENU
+Compare
EKSO
Stock ticker: NASDAQ
AS OF
May 8 closing price
Price
$0.41
Change
-$0.03 (-6.82%)
Capitalization
24.35M

EKSO Ekso Bionics Holdings Forecast, Technical & Fundamental Analysis

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets... Show more

EKSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for EKSO with price predictions
May 07, 2025

EKSO saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for EKSO moved out of overbought territory on May 06, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 45 similar instances where the indicator exited the overbought zone. In of the 45 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for EKSO moved out of overbought territory on April 29, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EKSO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EKSO broke above its upper Bollinger Band on April 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on EKSO as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EKSO just turned positive on April 15, 2025. Looking at past instances where EKSO's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

EKSO moved above its 50-day moving average on May 07, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for EKSO crossed bullishly above the 50-day moving average on May 01, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where EKSO advanced for three days, in of 261 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 117 cases where EKSO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.875) is normal, around the industry mean (24.089). P/E Ratio (0.000) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.001) is also within normal values, averaging (42.249).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. EKSO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EKSO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
EKSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EKSO is expected to report earnings to fall 54.17% to -5 cents per share on July 24

Ekso Bionics Holdings EKSO Stock Earnings Reports
Q2'25
Est.
$-0.05
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.05
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.13
The last earnings report on May 05 showed earnings per share of -11 cents, missing the estimate of -7 cents. With 117.77K shares outstanding, the current market capitalization sits at 24.35M.
A.I. Advisor
published General Information

General Information

a robotic exoskeleton company, which designs and develops exoskeletons and wearable robots

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
101 Glacier Point
Phone
+1 510 984-1761
Employees
73
Web
https://www.eksobionics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCE22.230.98
+4.61%
BCE
EVEX3.810.15
+4.10%
Eve Holding
IPGP58.730.85
+1.47%
IPG Photonics Corp
WSBF12.420.16
+1.31%
Waterstone Financial
BIAF0.20-0.01
-5.31%
bioAffinity Technologies

EKSO and Stocks

Correlation & Price change

A.I.dvisor tells us that EKSO and RCEL have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EKSO and RCEL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EKSO
1D Price
Change %
EKSO100%
-5.72%
RCEL - EKSO
29%
Poorly correlated
-1.43%
MBOT - EKSO
28%
Poorly correlated
+1.99%
TMDX - EKSO
25%
Poorly correlated
-2.72%
ATEC - EKSO
25%
Poorly correlated
+2.33%
PAVM - EKSO
24%
Poorly correlated
-8.49%
More